MoonLake Immunotherapeutics — SCHEDULE 13G/A Filings
6 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by MoonLake Immunotherapeutics (MLTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. MoonLake Immunotherapeutics has filed 6 SCHEDULE 13G/A documents with the SEC since 2020. To view all SEC filings by MoonLake Immunotherapeutics, see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DRS
EFFECT
NT 10-Q
POS AM
PREM14A
PRER14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000902664-25-004943 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002792 | Nov 5, 2025 | — |
| SCHEDULE 13G/A | — | 0000929638-25-003714 | Oct 1, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002044 | Aug 6, 2025 | — |
| SCHEDULE 13G/A | — | 0000080255-25-000373 | May 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-000896 | Feb 12, 2025 | — |